AJANTA PHARMA LTD.

Scale -

Revenue is 5453 Rs Cr; Annual Growth is 17 %; Continuous Growth over 3 years; 5 Year CAGR is 13 %
Ebitda is 1567 Rs Cr; Annual Growth is 16 %; Continuous Growth over 3 years; 5 Year CAGR is 11 %
PBT is 447 Rs Cr; Annual Growth is 16 %; 5 Year CAGR is 11 %
PAT is 1056 Rs Cr; Continuous Growth over 3 years; 5 Year CAGR is 10 %
Quarterly Revenue is 1626 Rs Cr; Continuous Growth over 3 Quarters

Profitability -

Quarterly Profit margin is 21 %; in Top Quartile

PBDIT Margin is 28.73 %; Continuous Decline over 3 years

Return -

Asset Turnover is 98 %; Continuous Growth over 3 years; in Top Quartile
ROCE is 29.4 %; in Top Quartile
ROA is 17.15 %; in Top Quartile
ROE is 23.32 %; in Top Quartile

Efficiency -

Inventory Turnover Ratio is 5.92; Continuous Growth over 3 years; in Top Quartile; 5 Year CAGR is 52 %

Operating cash flow is 529 Rs Cr; Annual Decline is -54 %
Current Ratio is 2.64; Continuous Decline over 3 years

Solvancy -

Total Debt is 212 Rs Cr; Annual Growth is 8085 %; Continuous Growth over 3 years; 5 Year CAGR is 225 %
Contingent Liabilities is 312 Rs Cr; Annual Growth is 116 %; 5 Year CAGR is 42 %

Quality -

Current Tax/PAT is 28 %; Annual Decline is -22 %

Operating cashflow/ebitda is 34 %; Annual Decline is -60 %; in Bottom Quartile
Operating cashflow/PAT is 50 %; Annual Decline is -60 %; in Bottom Quartile
Change in Inventories/Total Expenses is 1 %; Annual Growth is 222 %; Continuous Growth over 3 years; in Top Quartile
Other Expenses/Total Expenses is 37 %; Continuous Growth over 3 years; in Top Quartile
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: